is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Seegene, a Frontier of High Multiplex HPV Screening.
Now provides up to 15 targets quantification information in a single tube using 3 Ct PCR technology. Seegene’s latest leading-edge technology can quantify 15 targets in a single tube. This proprietary technology is applied to Allplex™ HPV HR/28 Detection assays and provides the broadest clinical information while screening HPVs. The results of these informative tests will enable the clinician to make no guesses and to perform true syndromic quantitative testing, allowing prioritization of treatment strategies for multiple infections and composite drug resistance.